Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · IEX Real-Time Price · USD
1.320
+0.010 (0.76%)
At close: Jul 19, 2024, 4:00 PM
1.280
-0.040 (-3.03%)
Pre-market: Jul 22, 2024, 7:15 AM EDT
Aclaris Therapeutics Stock Forecast
ACRS's stock price has decreased by -87.34% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ACRS stock have an average target of 11.5, with a low estimate of 1.00 and a high estimate of 22. The average target predicts an increase of 771.21% from the current stock price of 1.32.
Analyst Consensus: Hold
* Price targets were last updated on Dec 18, 2023.
Analyst Ratings
The average analyst rating for ACRS stock from 6 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jul 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 22, 2024 |
BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +581.82% | Dec 29, 2023 |
Stifel | Stifel | Hold Maintains $2 → $1 | Hold | Maintains | $2 → $1 | -24.24% | Dec 18, 2023 |
Financial Forecast
Revenue This Year
8.05M
from 31.25M
Decreased by -74.26%
Revenue Next Year
7.89M
from 8.05M
Decreased by -1.88%
EPS This Year
-0.81
from -1.27
EPS Next Year
-0.64
from -0.81
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 10.7M | 12.8M | 13.4M | 31.7M | 63.2M |
Avg | 8.0M | 7.9M | 7.7M | 14.8M | 32.6M |
Low | 4.3M | 2.6M | 2.6M | 5.8M | 5.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -65.8% | 59.1% | 70.3% | 311.0% | 326.2% |
Avg | -74.3% | -1.9% | -2.3% | 92.2% | 120.1% |
Low | -86.3% | -68.0% | -67.4% | -25.1% | -60.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.56 | -0.42 | -0.39 | -0.32 | 0.01 |
Avg | -0.81 | -0.64 | -0.61 | -0.31 | -0.15 |
Low | -1.19 | -1.32 | -1.23 | -0.30 | -0.30 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.